Xcell Biosciences is based in San Francisco. It has raised $17M in total funding. Latest round: Series B.
Xcell Biosciences is based in San Francisco. Xcell Biosciences has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Xcell Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Casdin Capital, Dynamk Capital, Formic Ventures, Labcorp, HBM Genomics, Viking Global Investors. 6 distinct backers are named across the disclosed rounds.
We update the Xcell Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Francisco and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026